A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele

BMC Medical Genetics

Volumn 9, Issue , 2008, Pages

  Haasl, Ryan J ^a,b   Reza, M Reza ^a   Meethal, Sivan Vadakkadath ^a,b   Gleason, Carey E ^a,b   Johnson, Sterling C ^a,b   Asthana, Sanjay ^a,b   Bowen, Richard L ^c   Atwood, Craig S ^a,b,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c OTB Research   (United States)

^d EDITH COWAN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; LUTEINIZING HORMONE BETA SUBUNIT; LUTEINIZING HORMONE RECEPTOR; NEUROSTEROID; STEROID;

AGED; ALLELE; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; BIOCHEMISTRY; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTRON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; STEROIDOGENESIS; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; EXON; GENETICS; ONSET AGE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EXONS; FEMALE; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; LUTEINIZING HORMONE, BETA SUBUNIT; MALE; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; RECEPTORS, LH; RISK FACTORS; SEX FACTORS;

EID: 44349083202     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-9-37     Document Type: Article

References (60)

1. Bertram L Tanzi RE The current status of Alzheimer's disease genetics: what do we tell the patients? Pharmacol Res 2004, 50:385-396 10.1016/ j.phrs.2003.11.018 15304236
2. Corder EH Saunders AM Strittmatter WJ Schmechel DE Gaskell PC Small GW Roses AD Haines JL Pericak-Vance MA Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 1993, 261:921-923 10.1126/science.8346443 8346443
3. Saunders AM Strittmatter WJ Schmechel D George-Hyslop PH Pericak-Vance MA Joo SH Rosi BL Gusella JF Crapper-MacLachlan DR Alberts MJ Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 1993, 43:1467-1472 8350998
4. Farrer LA Cupples LA Haines JL Hyman B Kukull WA Mayeux R Myers RH Pericak-Vance MA Risch N van Duijn CM Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium Jama 1997, 278:1349-1356 10.1001/jama.278.16.1349 9343467
5. Roses A Devlin B Conneally P Small G Saunders A Pritchard M Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am J Hum Genet 1995, 57:A202
6. Daw EW Payami H Nemens EJ Nochlin D Bird TD Schellenberg GD Wijsman EM The number of trait loci in late-onset Alzheimer disease Am J Hum Genet 2000, 66:196-204 1288326 10631151 10.1086/302710
7. Chapuis J Tian J Shi J Bensemain F Cottel D Lendon C Amouyel P Mann D Lambert JC Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease Neurobiol Aging 2006, 27:1212-1215 10.1016/j.neurobiolaging.2005.07.013 16154235
8. Ozturk A DeKosky ST Kamboh MI Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease Neurosci Lett 2006, 406:265-269 10.1016/ j.neulet.2006.07.054 16914266
9. Pritchard A Harris J Pritchard CW St Clair D Lemmon H Lambert JC Chartier-Harlin MC Hayes A Thaker U Iwatsubo T Mann DM Lendon C Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease Neurosci Lett 2005, 382:221-226 10.1016/j.neulet.2005.03.016 15925094
10. Monastero R Cefalu AB Camarda C Noto D Camarda LK Caldarella R Imbornone E Averna MR Camarda R Association of estrogen receptor alpha gene with Alzheimer's disease: A case-control study J Alzheimers Dis 2006, 9:273-278 16914837
11. Pirskanen M Hiltunen M Mannermaa A Helisalmi S Lehtovirta M Hanninen T Soininen H Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women Eur J Hum Genet 2005, 13:1000-1006 10.1038/sj.ejhg.5201447 15944651
12. Bowen RL Isley JP Atkinson RL An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 2000, 12:351-354 10.1046/j.1365-2826.2000.00461.x 10718932
13. Short RA Bowen RL O'Brien PC Graff-Radford NR Elevated gonadotropin levels in patients with Alzheimer disease Mayo Clin Proc 2001, 76:906-909 11560301
14. Hogervorst E Bandelow S Combrinck M Smith AD Low free testosterone is an independent risk factor for Alzheimer's disease Exp Gerontol 2004, 39:1633-1639 10.1016/j.exger.2004.06.019 15582279
15. Lukacs H Hiatt ES Lei ZM Rao CV Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats Horm Behav 1995, 29:42-58 10.1006/hbeh.1995.1004 7782062
16. Lei ZM Rao CV Novel presence of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and the down-regulating action of hCG on gonadotropin-releasing hormone gene expression in immortalized hypothalamic GT1-7 neurons Mol Endocrinol 1994, 8:1111-1121 10.1210/ me.8.8.1111 7997235
17. Bowen RL Verdile G Liu T Parlow AF Perry G Smith MA Martins RN Atwood CS Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition J Biol Chem 2004, 279:20539-20545 10.1074/jbc.M311993200 14871891
18. Casadesus G Atwood CS Bowen RL Smith MA Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP tansgenic mice. Biochem Biophys Acta 2006
19. Liu T Wimalasena J Bowen RL Atwood CS Luteinizing hormone receptor mediates neuronal pregnenolone production via up-regulation of steroidogenic acute regulatory protein expression J Neurochem 2007, 100:1329-1339 10.1111/j.1471-4159.2006.04307.x 17241129
20. Weill-Engerer S David JP Sazdovitch V Liere P Eychenne B Pianos A Schumacher M Delacourte A Baulieu EE Akwa Y Neurosteroid quantification in human brain regions: Comparison between Alzheimer's and nondemented patients J Clin Endocrinol Metab 2002, 87:5138-5143 10.1210/ jc.2002-020878 12414884
21. Simpkins JW Yang SH Wen Y Singh M Estrogens, progestins, menopause and neurodegeneration: Basic and clinical studies Cell Mol Life Sci 2005, 62:271-280 10.1007/s00018-004-4382-2 15723163
22. Mahley RW Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology Science 1988, 240:622-630 10.1126/science.3283935 3283935
23. Andersen OM Willnow TE Lipoprotein receptors in Alzheimer's disease Trends Neurosci 2006, 29:687-694 10.1016/j.tins.2006.09.002 17000013
24. Themmen APN Huhtaniemi IT Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function Endocr Rev 2000, 21:551-583 10.1210/ er.21.5.551 11041448
25. Huhtaniemi IT Themmen AP Mutations in human gonadotropin and gonadotropin-receptor genes Endocrine 2005, 26:207-217 10.1385/ ENDO:26:3:207 16034174
26. Furui K Suganuma N Tsukahara S Asada Y Kikkawa F Tanaka M Ozawa T Tomoda Y Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants J Clin Endocrinol Metab 1994, 78:107-113 10.1210/jc.78.1.107 7904610
27. Takahashi K Kurioka H Ozaki T Kanasaki H Miyazaki K Karino K Pituitary response to luteinizing hormone-releasing hormone in women with variant luteinizing hormone Eur J Endocrinol 2000, 143:375-381 10.1530/ eje.0.1430375 11022180
28. Muller T Gromoll J Simoni M Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action J Clin Endocrinol Metab 2003, 88:2242-2249 10.1210/jc.2002-021946 12727981
29. Richter-Unruh A Martens JW Verhoef-Post M Wessels HT Kors WA Sinnecker GH Boehmer A Drop SL Toledo SP Brunner HG Themmen AP Leydig cell hypoplasia: Cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene Clin Endocrinol (Oxf) 2002, 56:103-112 10.1046/j.0300-0664.2001.01437.x 11849253
30. Ashley-Koch AE Mei H Jaworski J Ma DQ Ritchie MD Menold MM Delong GR Abramson RK Wright HH Hussman JP Cuccaro ML Gilbert JR Martin ER Pericak-Vance MA An analysis paradigm for investigating multi-locus effects in complex disease: Examination of three GABA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder Ann Hum Genet 2006, 70:281-292 10.1111/j.1469-1809.2006.00253.x 16674551
31. Ghebremedhin E Schultz C Thal DR Rub U Ohm TG Braak E Braak H Gender and age modify the association between APOE and AD-related neuropathology Neurology 2001, 56:1696-1701 11425936
32. Payami H Zareparsi S Montee KR Sexton GJ Kaye JA Bird TD Yu CE Wijsman EM Heston LL Litt M Schellenberg GD Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: A possible clue to the higher incidence of Alzheimer disease in women Am J Hum Genet 1996, 58:803-811 1914663 8644745
33. Lehmann DJ Butler HT Warden DR Combrinck M King E Nicoll JA Budge MM de Jager CA Hogervorst E Esiri MM Ragoussis J Smith AD Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men Neurosci Lett 2003, 340:87-90 10.1016/S0304-3940(03)00069-7 12668243
34. Smith MA Perry G Atwood CS Bowen RL Estrogen replacement and risk of Alzheimer disease Jama 2003, 289:1100; author reply 1101 2
35. Meethal SV Smith MA Bowen RL Atwood CS The gonadotropin connection in Alzheimer's disease Endocrine 2005, 26:317-326 10.1385/ENDO:26:3:317 16034187
36. Strittmatter WJ Weisgraber KH Huang DY Dong LM Salvesen GS Pericak-Vance M Schmechel D Saunders AM Goldgaber D Roses AD Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease Proc Natl Acad Sci U S A 1993, 90:8098-8102 47295 8367470 10.1073/pnas.90.17.8098
37. Fazekas F Enzinger C Ropele S Schmidt H Schmidt R Strasser-Fuchs S The impact of our genes: Consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis J Neurol Sci 2006, 245:35-39 10.1016/j.jns.2005.08.018 16631796
38. Zhang G Curtiss LK Wade RL Dyer CA An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17alpha-hydroxylase, C17-20 lyase J Lipid Res 1998, 39:2406-2414 9831628
39. Foster JD Strauss JF 3rd Paavola LG Cellular events involved in hormonal control of receptor-mediated endocytosis: Regulation occurs at multiple sites in the low density lipoprotein pathway, including steps beyond the receptor Endocrinology 1993, 132:337-350 10.1210/en.132.1.337 8419131
40. Milne RL Ribas G Gonzalez-Neira A Fagerholm R Salas A Gonzalez E Dopazo J Nevanlinna H Robledo M Benitez J ERCC4 Associated with Breast Cancer Risk: A Two-Stage Case-Control Study Using High-throughput Genotyping Cancer Res 2006, 66:9420-9427 10.1158/0008-5472.CAN-06-1418 17018596
41. Yu Y Panhuysen C Kranzler HR Hesselbrock V Rounsaville B Weiss R Brady K Farrer LA Gelernter J Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans Hum Mol Genet 2006, 15:2192-2199 10.1093/hmg/ddl144 16740595
42. Lin SL Miller JD Ying SY Intronic MicroRNA (miRNA) J Biomed Biotechnol 2006, 2006:26818 1559912 17057362
43. Wessagowit V Nalla VK Rogan PK McGrath JA Normal and abnormal mechanisms of gene splicing and relevance to inherited skin diseases J Dermatol Sci 2005, 40:73-84 1351063 16054339 10.1016/j.jdermsci.2005.05.006
44. Matlin AJ Clark F Smith CW Understanding alternative splicing: Towards a cellular code Nat Rev Mol Cell Biol 2005, 6:386-398 10.1038/nrm1645 15956978
45. Churbanov A Rogozin IB Deogun JS Ali H Method of predicting splice sites based on signal interactions Biol Direct 2006, 1:10 1526722 16584568 10.1186/1745-6150-1-10
46. Lewis P Zaykin D Computer program for the analysis of allelic data. Version 1.0(d16c). 2007 http://hydrodictyon.eeb.uconn.edu/people/plewis/ software.php
47. Minitab Minitab v 14.0 State College, PA
48. Lancaster A Nelson MP Meyer D Thomson G Single RM PyPop: A software framework for population genomics: Analyzing large-scale multi-locus genotype data Pac Symp Biocomput 2003, 514-525 12603054
49. Hahn LW Ritchie MD Moore JH Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions Bioinformatics 2003, 19:376-382 10.1093/bioinformatics/btf869 12584123
50. Thornton-Wells TA Moore JH Haines JL Genetics, statistics and human disease: Analytical retooling for complexity Trends Genet 2004, 20:640-647 10.1016/j.tig.2004.09.007 15522460
51. Peduzzi P Concato J Kemper E Holford TR Feinstein AR A simulation study of the number of events per variable in logistic regression analysis J Clin Epidemiol 1996, 49:1373-1379 10.1016/S0895-4356(96)00236-3 8970487
52. Ritchie MD Hahn LW Roodi N Bailey LR Dupont WD Parl FF Moore JH Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer Am J Hum Genet 2001, 69:138-147 1226028 11404819 10.1086/321276
53. Moore JH The ubiquitous nature of epistasis in determining susceptibility to common human diseases Hum Hered 2003, 56:73-82 10.1159/ 000073735 14614241
54. Coffey CS Hebert PR Ritchie MD Krumholz HM Gaziano JM Ridker PM Brown NJ Vaughan DE Moore JH An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: The importance of model validation BMC Bioinformatics 2004, 5:49 419697 15119966 10.1186/ 1471-2105-5-49
55. Motsinger AA Ritchie MD The effect of reduction in cross-validation intervals on the performance of multifactor dimensionality reduction Genet Epidemiol 2006, 30:546-555 10.1002/gepi.20166 16800004
56. Moore JH Williams SM New strategies for identifying gene-gene interactions in hypertension Ann Med 2002, 34:88-95 10.1080/ 07853890252953473 12108579
57. Williams SM Addy JH Phillips JA 3rd Dai M Kpodonu J Afful J Jackson H Joseph K Eason F Murray MM Epperson P Aduonum A Wong LJ Jose PA Felder RA Combinations of variations in multiple genes are associated with hypertension Hypertension 2000, 36:2-6 10904004
58. Jiang M Lamminen T Pakarinen P Hellman J Manna P Herrera RJ Huhtaniemi I A novel Ala(-3)Thr mutation in the signal peptide of human luteinizing hormone beta-subunit: Potentiation of the inositol phosphate signalling pathway and attenuation of the adenylate cyclase pathway by recombinant variant hormone Mol Hum Reprod 2002, 8:201-212 10.1093/molehr/8.3.201 11870227
59. Atger M Misrahi M Sar S Le Flem L Dessen P Milgrom E Structure of the human luteinizing hormone-choriogonadotropin receptor gene: Unusual promoter and 5' non-coding regions Mol Cell Endocrinol 1995, 111:113-123 10.1016/0303-7207(95)03557-N 7556872
60. Kremer H Martens JW van Reen M Verhoef-Post M Wit JM Otten BJ Drop SL Delemarre-van de Waal HA Pombo-Arias M De Luca F Potau N Buckler JM Jansen M Parks JS Latif HA Moll GW Epping W Saggese G Mariman EC Themmen AP Brunner HG A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty J Clin Endocrinol Metab 1999, 84:1136-1140 10.1210/jc.84.3.1136 10084607